Brief: Orion Terminates Odm-111 Development Program Due To Narrow Therapeutic Window Of The Molecule
Oct 24 (Reuters) - Orion Oyj ORNBV.HE :
* INSIDE INFORMATION: ORION TERMINATES ODM-111 DEVELOPMENT
PROGRAM
DUE TO NARROW THERAPEUTIC WINDOW OF THE MOLECULE
* ORION OYJ - ODM-111 MOLECULE PROFILE DOES NOT SUPPORT
LONG-TERM
USE
* ORION OYJ - PHASE I TRIALS SHOW NO SIGNIFICANT SAFETY
CONCERNS
FOR ODM-111
Source text for Eikon: ID:nGNE5WscFV
Further company coverage: ORNBV.HE
((Reuters.Briefs@thomsonreuters.com;))